David Green
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 0.2%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Hematology 114
- Platelet Disorders and Treatments 43
- Hemophilia Treatment and Research 39
- Blood Coagulation and Thrombosis Mechanisms 37
-
- Venous Thromboembolism Diagnosis and Management 24
- Co-authors
- Klaus Lechner (1 shared paper)Shahin Rafii (2 shared papers)Robert Möhle (1 shared paper)Ralph L. Nachman (1 shared paper)Malcolm A.S. Moore (1 shared paper)Kiang Liu (28 shared papers)Mary McGrae McDermott (23 shared papers)Michael H. Criqui (19 shared papers)
- Journals
- Thrombosis and Haemostasis (14 papers)The American Journal of Medicine (11 papers)The Lancet (10 papers)Blood (10 papers)Emergency Medicine Australasia (9 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
David Green
309 papers receiving 11.6k citations
David Green's Hit Papers
Peers
Comparison fields: 5 of 166
- Internal Medicine 773
- Hematology 3.1k
- Infectious Diseases 1.1k
- Rheumatology 775
- Pathology and Forensic Medicine 885
Countries citing papers authored by David Green
This map shows the geographic impact of David Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Green more than expected).
Fields of papers citing papers by David Green
This network shows the impact of papers produced by David Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Green. The network helps show where David Green may publish in the future.
Co-authors
The 25 scholars most cited alongside David Green, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 334 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project Hit paper breakdown → | 2009 | 740 |
| 2 | A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome Hit paper breakdown → | 2003 | 709 |
| 3 | Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Hit paper breakdown → | 1997 | 626 |
| 4 | A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII Hit paper breakdown → | 1981 | 625 |
| 5 | 2005 | 406 | |
| 6 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 7 | Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication Hit paper breakdown → | 2009 | 356 |
| 8 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 9 | 1975 | 280 | |
| 10 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 11 | 2010 | 213 | |
| 12 | 2021 | 213 | |
| 13 | 1993 | 201 | |
| 14 | 2003 | 188 | |
| 15 | 2021 | 173 | |
| 16 | 2008 | 148 | |
| 17 | 1992 | 146 | |
| 18 | 2012 | 146 | |
| 19 | 1962 | 137 | |
| 20 | 2008 | 130 |
About David Green
David Green is a scholar working on Hematology, Internal Medicine, Emergency Medicine, Surgery and Biochemistry, having authored 334 papers that have together received 12.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (43 papers), Hemophilia Treatment and Research (39 papers), Blood Coagulation and Thrombosis Mechanisms (37 papers), Peripheral Artery Disease Management (24 papers), Venous Thromboembolism Diagnosis and Management (24 papers), Emergency and Acute Care Studies (17 papers), Blood transfusion and management (13 papers) and Blood properties and coagulation (8 papers). The work is most often cited by research in Internal Medicine (773 citations), Hematology (3.1k citations), Infectious Diseases (1.1k citations), Rheumatology (775 citations) and Pathology and Forensic Medicine (885 citations). David Green has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Klaus Lechner, Shahin Rafii, Robert Möhle, Ralph L. Nachman, Malcolm A.S. Moore, Kiang Liu, Mary McGrae McDermott, Michael H. Criqui, Jack M. Guralnik and Lisa N. Boggio. Their work appears in journals such as Thrombosis and Haemostasis, The American Journal of Medicine, The Lancet, Blood and Emergency Medicine Australasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.